Enanta Pharmaceuticals, Inc. - Common Stock (ENTA)
7.2700
+0.0400 (0.55%)
Enanta Pharmaceuticals is a biotechnology company focused on discovering and developing innovative therapies for infectious diseases and liver diseases
The company specializes in the research and development of small molecule drugs, primarily targeting viral infections such as hepatitis B and hepatitis C, as well as other serious medical conditions. Enanta collaborates with pharmaceutical partners to advance its pipeline of novel antiviral therapeutics, aiming to address unmet medical needs and improve patient outcomes through its scientific expertise and commitment to drug development.
Frequently Asked Questions
Is Enanta Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Enanta Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Enanta Pharmaceuticals, Inc. - Common Stock trade on?
Enanta Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Enanta Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Enanta Pharmaceuticals, Inc. - Common Stock is ENTA on the Nasdaq Stock Market
What is the current price of Enanta Pharmaceuticals, Inc. - Common Stock?
The current price of Enanta Pharmaceuticals, Inc. - Common Stock is 7.270
When was Enanta Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Enanta Pharmaceuticals, Inc. - Common Stock was at 4:00 pm EDT on March 12th, 2025
What is the market capitalization of Enanta Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Enanta Pharmaceuticals, Inc. - Common Stock is 153.07M
How many shares of Enanta Pharmaceuticals, Inc. - Common Stock are outstanding?
Enanta Pharmaceuticals, Inc. - Common Stock has 21.06M shares outstanding.